FULC Fulcrum Tx Bozor qiymatining balans qiymatiga nisbati

Fulcrum Tx - FULC emitenti grafik logotipi

GURU.Markets platformasida ko'rsatilgan Fulcrum Therapeutics (FULC) narx trayektoriyasi aktiv dinamikasini namoyish etadi va uning ko'rsatkichi hozirda 0.93 darajasida turibdi. Fulcrum Therapeutics kimyoviy reagentlarni qayta ishlash va bioetikani yaxshilash orqali ESG tamoyillarini joriy qilmoqda. Kompaniya noyob patologiyalarni monetizatsiya qilish uchun gen terapiyasi patentlariga tayanadi, garchi hozirda tadqiqot xarajatlarini qisqartirib, anemiya terapiyasiga e'tibor qaratish orqali o'z strategik yo'nalishini o'zgartirayotgan bo'lsa-da.

Fulcrum Corp (FULC) Sof aktivlarga nisbatan bozor kapitallashuvi: 04.07.2022 - 30.10.2026 davri uchun
Fulcrum Therapeutics Inc yetakchi tovari

Kamyob kasalliklarga qarshi kurashish uchun yetakchi genetiklarni birlashtirgan Fulcrum Therapeutics (FULC) kompaniyasi uchun operatsion risklar va kapital rentabelligi o'rtasidagi muvozanatni topish fundamental qiymat tahlilini talab qiladi. Bozor qiymatining buxgalteriya qiymatiga nisbati bo'lgan ushbu koeffitsiyent joriy kotirovkani sof aktivlar bilan solishtiradi, bu esa investorga aktivning haddan tashqari sotib olingan holatini va mahalliy multiplikatorlarning eng past nuqtalarida sotib olayotganda kapitalning qulflanib qolish ehtimolini baholash imkonini beradi.

Raqobatchilar tahlili

VRTX: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati alnylam.com|Bozor qiymatining balans qiymatiga nisbati Insmed|United Therapeutics Corp (UTHR) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati BioMarin Pharma (BMRN)|BBIO: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati BGM (BGM Group)|cogentbio.com (COGT) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Xeris Biopharma Holdings - Bozor kapitallashuvining balans qiymatiga nisbati|Keros Therapeutics Inc (KROS) - Kapitallashuvning sof aktivlarga nisbati|ARCT: Bozor kapitallashuvining balans qiymatiga nisbati|ETON - Balans qiymatiga nisbatan bozor kapitallashuvi|KMDA (Kamada Ltd.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Abeona|Bozor qiymatining balans qiymatiga nisbati Mereo BioPharma (MREO)|Bozor qiymatining balans qiymatiga nisbati PLX (Protalix BioTherapeutics Inc.)|Bozor kapitallashuvining balans qiymatiga nisbati PLRX (Pliant Therapeutics, Inc.)|Balans qiymatiga nisbatan bozor kapitallashuvi Applied Therapeutics Inc. (APLT)|RNTX: Kapitallashuvning sof aktivlarga nisbati|Sof aktivlarga nisbatan bozor kapitallashuvi GELS|AYTU: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Chemomab Therapeutics Ltd. (CMMB)|SRXH (SRx Health Solutions Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati PLRZ (Polyrizon Ltd.)|Kapitallashuvning sof aktivlarga nisbati AEZS (Aeterna Zentaris)|CYTH (cyclotherapeutics.com) - Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati Inozyme Pharma INZY|RPHM (Reneo Pharmaceuticals Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi|Aeterna Zentaris - Bozor kapitallashuvining balans qiymatiga nisbati